Statistics for Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients With Fingolimod Treatment (Vol 60, Pg 23, 2023)
Total visits
| views | |
|---|---|
| Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients With Fingolimod Treatment (Vol 60, Pg 23, 2023) | 2 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 1 |
| March 2026 | 0 |
Top country views
| views | |
|---|---|
| China | 1 |
| Turkey | 1 |
Top city views
| views | |
|---|---|
| Atakum | 1 |